Express News | Aurinia Pharmaceuticals to Release Second Quarter Financial and Operational Results on August 1, 2024

ReutersJul 19 06:00 ET

Aurinia (AUPH) Soars 6.6%: Is Further Upside Left in the Stock?

Aurinia Pharmaceuticals (AUPH Quick QuoteAUPH - Free Report) shares ended the last trading session 6.6% higher at $5.86. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 0.9% gain over the past four weeks.

Zacks Jul 12 04:45 ET

ILJIN SNT Co., Ltd. Calls on Board of Aurinia Pharmaceuticals to Honor Shareholders' Voices Expressed at the AGM

One of Company's Largest and Longest-Standing Shareholders Urges Board to Accept Director Resignations Announces Intentions to Maintain Vigilance and Continue Actions to Restore Shareholder Value ILJIN SNT Co., Ltd.

BusinesswireJul 11 15:27 ET

Aurinia to Participate in Upcoming Investor Healthcare Conferences

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (Aurinia or the Company) today announced that the Company's management team will participate in one-on-one meetings with investors at the Leerink Partners Therapeutics Forum:

BusinesswireJul 2 06:00 ET

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Most Popular Amongst Retail Investors Who Own 54% of the Shares, Institutions Hold 35%

Yahoo FinanceJun 28 15:44 ET

Aurinia Pharmaceuticals: Four Directors Received Less Than Majority Support at Annual Meeting

Aurinia Pharmaceuticals: Four Directors Received Less Than Majority Support at Annual Meeting

Dow JonesJun 14 12:19 ET